Jacobs Levy Equity Management
VCYT icon

Jacobs Levy Equity Management’s Veracyte VCYT Stock Holding History

Jacobs Levy Equity Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-12,463
Closed -$116K – 1080
2018
Q2 		$116K Buy
+12,463
New +$87.6K ﹤0.01% 990

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management's VCYT Position: Q3 2018 in Review

Jacobs Levy Equity Management sold out of Veracyte (VCYT) in Q3 2018, closing a stake of 12,463 shares — an estimated $116K sold.

Jacobs Levy Equity Management first reported a position in VCYT in Q2 2018 and held it in 1 quarter. The position peaked at $116K in Q2 2018. 111 funds tracked by Wall St. Rank hold VCYT as of Q3 2018.

  • Jacobs Levy Equity Management reported no remaining Veracyte position as of Q3 2018 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 12,463 Veracyte shares in Q3 2018, an estimated $116K.
  • Jacobs Levy Equity Management first reported a position in Veracyte in Q2 2018 and held it in 1 quarter.
  • Jacobs Levy Equity Management's Veracyte position peaked at $116K in Q2 2018.
  • 111 funds tracked by Wall St. Rank held Veracyte as of Q3 2018.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2018, filed 14 Nov 2018.